Brief: BioPharmX announces submission of pre-ind meeting request to U.S. FDA
02/12/2014 12:33
Dec 2 (Reuters) - BioPharmX Corp BPMX.OB : * Announces submission of pre-ind meeting request to the U.S. FDA for its topical acne solution * Source text for Eikon ID:nPn2w3GYk * Further company coverage BPMX.OB ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Trex Wind-Down
See all newsBrief: NYSE American To Suspend Trading Immediately In Timber Pharma
Brief: Timber Pharmaceuticals Receives Court Approval Of All “First Day” Motions To Support Business
Brief: NYSE American to Commence Delisting Proceedings Against Timber Pharmaceuticals
Brief: Timber Pharmaceuticals Says Prior To Filing Of Chapter 11 Case, Debtors Entered Into A "Stalking Horse" Asset Purchase Agreement
Brief: Timber Pharmaceuticals Inc Files For Voluntary Chapter 11 Bankruptcy - Court Filing